Moloney Securities Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.77M | Sell |
36,523
-556
| -1% | -$95.3K | 0.81% | 30 |
|
|
2025
Q2 | $5.66M | Buy |
37,079
+1,510
| +4% | +$232K | 0.7% | 25 |
|
|
2025
Q1 | $5.9M | Buy |
35,569
+1,872
| +6% | +$293K | 0.8% | 21 |
|
|
2024
Q4 | $4.87M | Sell |
33,697
-2,166
| -6% | -$336K | 0.65% | 39 |
|
|
2024
Q3 | $5.81M | Sell |
35,863
-142
| -0.4% | -$22.6K | 0.78% | 26 |
|
|
2024
Q2 | $5.26M | Buy |
36,005
+1,020
| +3% | +$152K | 0.76% | 29 |
|
|
2024
Q1 | $5.53M | Sell |
34,985
-836
| -2% | -$133K | 0.83% | 21 |
|
|
2023
Q4 | $5.61M | Sell |
35,821
-2,891
| -7% | -$443K | 0.89% | 16 |
|
|
2023
Q3 | $6.03M | Sell |
38,712
-936
| -2% | -$154K | 1.09% | 13 |
|
|
2023
Q2 | $6.56M | Sell |
39,648
-592
| -1% | -$95.5K | 1.16% | 13 |
|
|
2023
Q1 | $6.24M | Sell |
40,240
-468
| -1% | -$75.6K | 1.16% | 9 |
|
|
2022
Q4 | $7.19M | Sell |
40,708
-4,188
| -9% | -$723K | 1.59% | 5 |
|
|
2022
Q3 | $7.33M | Buy |
44,896
+650
| +1% | +$110K | 1.78% | 4 |
|
|
2022
Q2 | $7.85M | Sell |
44,246
-1,288
| -3% | -$229K | 1.84% | 3 |
|
|
2022
Q1 | $8.07M | Sell |
45,534
-8,349
| -15% | -$1.42M | 1.57% | 6 |
|
|
2021
Q4 | $9.22M | Sell |
53,883
-24
| -0% | -$3.93K | 1.57% | 4 |
|
|
2021
Q3 | $8.71M | Buy |
53,907
+688
| +1% | +$117K | 1.58% | 3 |
|
|
2021
Q2 | $8.77M | Sell |
53,219
-2,449
| -4% | -$405K | 1.6% | 3 |
|
|
2021
Q1 | $9.15M | Sell |
55,668
-5,269
| -9% | -$853K | 1.8% | 3 |
|
|
2020
Q4 | $9.59M | Sell |
60,937
-2,631
| -4% | -$388K | 2.13% | 3 |
|
|
2020
Q3 | $9.46M | Buy |
63,568
+3,107
| +5% | +$460K | 2.5% | 3 |
|
|
2020
Q2 | $8.5M | Sell |
60,461
-636
| -1% | -$92.7K | 2.47% | 3 |
|
|
2020
Q1 | $8.01M | Buy |
61,097
+8,210
| +16% | +$1.16M | 2.87% | 3 |
|
|
2019
Q4 | $7.71M | Buy |
52,887
+168
| +0.3% | +$22.8K | 2.38% | 3 |
|
|
2019
Q3 | $6.82M | Sell |
52,719
-1,608
| -3% | -$212K | 2.28% | 3 |
|
|
2019
Q2 | $7.57M | Buy |
54,327
+1,241
| +2% | +$172K | 2.52% | 2 |
|
|
2019
Q1 | $7.42M | Sell |
53,086
-1,296
| -2% | -$174K | 2.56% | 1 |
|
|
2018
Q4 | $7.02M | Buy |
54,382
+944
| +2% | +$132K | 2.87% | 1 |
|
|
2018
Q3 | $7.38M | Buy |
53,438
+603
| +1% | +$80.1K | 2.56% | 3 |
|
|
2018
Q2 | $6.41M | Buy |
52,835
+665
| +1% | +$83K | 2.43% | 3 |
|
|
2018
Q1 | $6.69M | Buy |
52,170
+1,763
| +3% | +$238K | 2.71% | 2 |
|
|
2017
Q4 | $7.04M | Sell |
50,407
-271
| -0.5% | -$37.7K | 2.96% | 1 |
|
|
2017
Q3 | $6.59M | Buy |
50,678
+1,529
| +3% | +$203K | 2.93% | 1 |
|
|
2017
Q2 | $6.5M | Buy |
49,149
+737
| +2% | +$94K | 3.24% | 1 |
|
|
2017
Q1 | $6.03M | Buy |
48,412
+6,925
| +17% | +$827K | 3.12% | 1 |
|
|
2016
Q4 | $4.78M | Buy |
+41,487
| New | +$4.79M | 2.89% | 2 |
|
Other funds holding JNJ
Moloney Securities Asset Management's JNJ Position: Q3 2025 in Review
Moloney Securities Asset Management reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q3 2025, selling an estimated $95.3K and leaving 36,523 shares worth $6.77M. The position accounts for 0.81% of the portfolio, ranked #30.
Moloney Securities Asset Management first reported a position in JNJ in Q4 2016 and has held it in 36 quarters since. The position peaked at $9.59M in Q4 2020. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.
- Moloney Securities Asset Management held 36,523 shares of Johnson & Johnson worth $6.77M as of Q3 2025.
- Moloney Securities Asset Management sold 556 Johnson & Johnson shares in Q3 2025, an estimated $95.3K.
- Johnson & Johnson made up 0.81% of Moloney Securities Asset Management's portfolio in Q3 2025, its #30 holding.
- Moloney Securities Asset Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 36 quarters since.
- Moloney Securities Asset Management's Johnson & Johnson position peaked at $9.59M in Q4 2020.
- 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.
Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.